Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
about
The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patientsAdhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic optionsClinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-AnalysisPreliminary study on proteomics of gastric carcinoma and its clinical significance.Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancerPrognostic value of preoperative serum tumor markers in gastric cancer.Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX.Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatmentCirculating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection.Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients.The identification and characterization of novel N-glycan-based biomarkers in gastric cancer.Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.Serum biomarker panels for the diagnosis of gastric adenocarcinoma.Body fluid MMP-2 as a putative biomarker in metastatic breast cancerPrognostic significance of tumor markers in T4a gastric cancerUpregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.Combined fibrinogen concentration and neutrophil-lymphocyte ratio as a prognostic marker of gastric cancer.Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancerHigh level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer.Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis.Microarray analysis in gastric cancer: a review.Lanthanide-doped luminescent nano-bioprobes for the detection of tumor markers.The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma.Unusually high serum CA19.9 in gastric carcinoma: A case report.Peritoneal recurrence in gastric cancer following curative resection can be predicted by postoperative but not preoperative biomarkers: a single-institution study of 320 cases.Discovery of gastric cancer specific biomarkers by the application of serum proteomics.Biological variation of serum neuron-specific enolase and carbohydrate antigen 724 tumor markers.The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.Rapid detection and quantification of tumor marker carbohydrate antigen 72-4 (CA72-4) using a superparamagnetic immunochromatographic strip.Gastric cancer: tumor markers as predictive factors for preoperative staging.Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.Clinical significance of primary tumor score determined by tumor depth and size in patients with resectable gastric cancer.
P2860
Q21131782-BE3BF5B5-9ABE-498C-A71D-C6AE452887C3Q26748666-6DE4B554-E5D6-47CB-AA1F-9FD1AB31168AQ26828549-5AC91A22-209E-4D14-AFA9-C7A173143AB8Q33231849-4BC74760-632F-45D1-8D62-A5BC81F8261CQ33473141-FE1BFDBA-EAE3-4ECE-8581-B6D615403ADFQ33585073-CBED5EAF-DA33-44F1-98EA-59A997CA8AC1Q33830752-700BFE1E-5EDD-4ACD-A39C-F46B5E344985Q34614931-3EF2B53C-0941-4FD8-B0BB-39685D9667B9Q34627153-6AC39E2E-6B79-45C5-A374-C0BF9BA12FCFQ34827623-479B2D05-B892-463B-8508-FDD6C21777C3Q34867093-C8ECBC41-20C8-4F83-B58E-0137CF3C614EQ35012088-A7ADA6BD-7542-42A0-8406-27B9B2AE42DDQ35023434-A845F84F-0347-48B8-B657-033A3EDA73DDQ35059969-26F3C343-A958-4D3B-A6D2-2BF0D074E29CQ35879848-5AC49380-5A80-4F63-8EAD-B9223F233F23Q35995497-923F61A5-D20E-48CD-AD72-37AF567952F5Q36125529-E66488D5-FFE3-4F4C-BDFA-20C87394354BQ36336377-C72D6622-F5D7-4B92-89C7-326DD8C06C71Q36492863-314126B3-F444-4CCB-B146-F683CE9F0D72Q36524772-A84C0C3D-E531-4A47-B1B6-3ED7DBCBBDEFQ36751568-352A08CE-325E-4BE7-A517-AC51860F45EBQ37118841-0B2FB2A3-7E9E-450F-83B3-36C70091F44DQ37287486-2A1487C9-1143-4C7D-918A-06C261728B0DQ37376581-2DDC4E52-D554-4453-81A5-08A4F8D10C9AQ37641050-8CBAFF0E-1F01-403C-A862-DEC5780CAF31Q37687145-8CB9A004-A121-4C55-BD29-B51CDF81FE17Q38251498-1793736F-5930-40BD-9362-435DBE6D47CAQ38297320-19356B84-EC49-4280-965D-DC2CEEAF5062Q39448761-56AFB51B-AC1A-42D3-BE39-E3873BBDCF0AQ40031823-8D2C1D63-A9F6-41BC-96D5-B0D5B9BBF1F6Q40430577-74D41182-2A8B-456D-B5FF-D6E279623483Q42878096-D27B5D99-0DE0-48C3-BA9E-7CCA817524A8Q47992332-76D82291-BE72-4D92-8348-70ACC36CF13BQ48323574-4FCC3210-164A-49C8-A8DF-D27FEC63F1ABQ50882005-2844168F-B5E4-431E-B91E-ABD1E4F80AD7Q51542145-AED10F52-844A-42FE-B371-01A3C370E29FQ51563865-EE1B22A3-D60D-4339-9A04-65EFAA01443EQ53130326-3E16BC93-6AEA-47D8-845E-2AA549796E8DQ54391859-B3786CF9-D3D6-4416-897E-677430208F7EQ55347241-6D5E3BFA-6C54-47B8-9CFB-904645AFBA57
P2860
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@ast
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@en
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@nl
type
label
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@ast
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@en
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@nl
prefLabel
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@ast
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@en
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@nl
P2093
P356
P1433
P1476
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
@en
P2093
M Díez-Alonso
M J Gaspar
P2888
P304
P356
10.1159/000050633
P577
2001-09-01T00:00:00Z
P6179
1024448109